Clinical Trials Browser

Phase 3 × INDUSTRY × Fluorodeoxyglucose F18 × Clear all

NCT06125028 2025-09-05

LYMFOR

Phase 3 Terminated

Lymphoma, B-Cell, Marginal Zone

NCT06416852 2024-05-16

Clinical Study of 18F-Alfatide Injection PET/CT

Phase 3 Not yet recruiting

Non-Small Cell Lung Cancer NSCLC